IL162562A0 - Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid - Google Patents

Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid

Info

Publication number: IL162562A0
Authority: IL; Israel
Prior art keywords: drug; substituted; imidazolid; diagnosis; production
Prior art date: 2001-12-21

Application number

IL16256202A

Other languages

English (en)

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-21

Filing date

2002-12-09

Publication date

2005-11-20

2002-12-09 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2005-11-20 Publication of IL162562A0 publication Critical patent/IL162562A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL16256202A 2001-12-21 2002-12-09 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid IL162562A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10163239A DE10163239A1 (de)	2001-12-21	2001-12-21	Substituierte Imidazolidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie enthaltendes Medikament
PCT/EP2002/013921 WO2003053434A1 (de)	2001-12-21	2002-12-09	Substituierte imidazolidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie enthaltendes medikament

Publications (1)

Publication Number	Publication Date
IL162562A0 true IL162562A0 (en)	2005-11-20

Family

ID=7710363

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16256202A IL162562A0 (en)	2001-12-21	2002-12-09	Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid
IL162562A IL162562A (en)	2001-12-21	2004-06-16	Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis and drug containing substituted imidazolidines

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL162562A IL162562A (en)	2001-12-21	2004-06-16	Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis and drug containing substituted imidazolidines

Country Status (27)

Country	Link
EP (1)	EP1461034B1 (zh)
JP (1)	JP4571803B2 (zh)
KR (1)	KR100959031B1 (zh)
CN (1)	CN100339079C (zh)
AR (1)	AR037932A1 (zh)
AT (1)	ATE345797T1 (zh)
AU (1)	AU2002361990B2 (zh)
BR (1)	BR0215154A (zh)
CA (1)	CA2470856A1 (zh)
CO (1)	CO5590925A2 (zh)
DE (2)	DE10163239A1 (zh)
DK (1)	DK1461034T3 (zh)
ES (1)	ES2275945T3 (zh)
HR (1)	HRP20040573A2 (zh)
HU (1)	HUP0600836A2 (zh)
IL (2)	IL162562A0 (zh)
MA (1)	MA27149A1 (zh)
MX (1)	MXPA04005388A (zh)
MY (1)	MY134344A (zh)
NO (1)	NO20043009L (zh)
PE (1)	PE20030741A1 (zh)
PL (1)	PL368940A1 (zh)
RS (1)	RS53204A (zh)
RU (1)	RU2004122415A (zh)
TW (1)	TW200305408A (zh)
WO (1)	WO2003053434A1 (zh)
ZA (1)	ZA200404149B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10323701A1 (de)	2003-05-22	2004-12-23	Aventis Pharma Deutschland Gmbh	Verfahren zur Synthese heterocyclischer Verbindungen
JP4384635B2 (ja)	2003-06-30	2009-12-16	住友化学株式会社	不斉尿素化合物およびこれを触媒として用いる不斉共役付加反応による不斉化合物の製造方法
DE10341240A1 (de) *	2003-09-08	2005-04-07	Aventis Pharma Deutschland Gmbh	Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP3173408B1 (en)	2014-07-25	2018-11-21	Taisho Pharmaceutical Co., Ltd.	Phenyl tetrahydroisoquinoline compound substituted with heteroaryl

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3190802A (en) *	1961-10-09	1965-06-22	Boehringer Sohn Ingelheim	Shaving composition and method of using same
US3236857A (en) *	1961-10-09	1966-02-22	Boehringer Sohn Ingelheim	2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products
EP0070084A3 (en) *	1981-04-24	1983-02-16	Beecham Group Plc	Imidazoline derivatives
DE3712385A1 (de) *	1987-04-11	1988-10-27	Boehringer Ingelheim Kg	2-(phenylimino)imidazolidine
GB9313330D0 (en) *	1993-06-28	1993-08-11	Fujisawa Pharmaceutical Co	New compound and its preparation
EP0639573A1 (de) *	1993-08-03	1995-02-22	Hoechst Aktiengesellschaft	Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
DE4328869A1 (de) *	1993-08-27	1995-03-02	Hoechst Ag	Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
KR100257129B1 (ko) *	1993-09-11	2000-05-15	성재갑	신규 세팔로스포린계 항생제 및 이의 제조방법
US5552415A (en) *	1993-12-21	1996-09-03	Eli Lilly And Company	Method of inhibiting Alzheimer's Disease
DE19548812A1 (de) *	1995-12-27	1997-07-03	Hoechst Ag	Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation
DE19633966A1 (de) *	1996-08-22	1998-02-26	Hoechst Ag	Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0966465B1 (en) *	1997-03-14	2003-07-09	Vertex Pharmaceuticals Incorporated	Inhibitors of impdh enzyme
DE19945302A1 (de) *	1999-09-22	2001-03-29	Merck Patent Gmbh	Biphenylderivate als NHE-3-Inhibitoren
DE19950898A1 (de) *	1999-10-22	2001-04-26	Aventis Pharma Gmbh	Heterocyclisch substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19960204A1 (de) *	1999-12-14	2001-06-28	Aventis Pharma Gmbh	Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10015248A1 (de) *	2000-03-28	2001-10-04	Merck Patent Gmbh	Bisamidino-Verbindungen als NHE-3 Inhibitoren
DE10019062A1 (de) *	2000-04-18	2001-10-25	Merck Patent Gmbh	2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren
DE10060292A1 (de) *	2000-12-05	2002-06-20	Aventis Pharma Gmbh	Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament

2001
- 2001-12-21 DE DE10163239A patent/DE10163239A1/de not_active Withdrawn
2002
- 2002-12-09 RU RU2004122415/04A patent/RU2004122415A/ru not_active Application Discontinuation
- 2002-12-09 HR HR20040573A patent/HRP20040573A2/hr not_active Application Discontinuation
- 2002-12-09 JP JP2003554191A patent/JP4571803B2/ja not_active Expired - Fee Related
- 2002-12-09 KR KR1020047009820A patent/KR100959031B1/ko not_active Expired - Fee Related
- 2002-12-09 HU HU0600836A patent/HUP0600836A2/hu unknown
- 2002-12-09 EP EP02796586A patent/EP1461034B1/de not_active Expired - Lifetime
- 2002-12-09 IL IL16256202A patent/IL162562A0/xx unknown
- 2002-12-09 AT AT02796586T patent/ATE345797T1/de not_active IP Right Cessation
- 2002-12-09 WO PCT/EP2002/013921 patent/WO2003053434A1/de not_active Ceased
- 2002-12-09 CA CA002470856A patent/CA2470856A1/en not_active Abandoned
- 2002-12-09 RS YU53204A patent/RS53204A/sr unknown
- 2002-12-09 AU AU2002361990A patent/AU2002361990B2/en not_active Ceased
- 2002-12-09 PL PL02368940A patent/PL368940A1/xx not_active Application Discontinuation
- 2002-12-09 MX MXPA04005388A patent/MXPA04005388A/es active IP Right Grant
- 2002-12-09 ES ES02796586T patent/ES2275945T3/es not_active Expired - Lifetime
- 2002-12-09 DK DK02796586T patent/DK1461034T3/da active
- 2002-12-09 DE DE50208809T patent/DE50208809D1/de not_active Expired - Lifetime
- 2002-12-09 CN CNB028258177A patent/CN100339079C/zh not_active Expired - Fee Related
- 2002-12-09 BR BR0215154-5A patent/BR0215154A/pt not_active IP Right Cessation
- 2002-12-11 PE PE2002001194A patent/PE20030741A1/es not_active Application Discontinuation
- 2002-12-19 AR ARP020105018A patent/AR037932A1/es unknown
- 2002-12-19 TW TW091136596A patent/TW200305408A/zh unknown
- 2002-12-20 MY MYPI20024821A patent/MY134344A/en unknown
2004
- 2004-05-27 ZA ZA200404149A patent/ZA200404149B/en unknown
- 2004-06-01 MA MA27709A patent/MA27149A1/fr unknown
- 2004-06-16 IL IL162562A patent/IL162562A/en not_active IP Right Cessation
- 2004-06-17 CO CO04056920A patent/CO5590925A2/es not_active Application Discontinuation
- 2004-07-15 NO NO20043009A patent/NO20043009L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
RU2004122415A (ru)	2005-03-27
DE10163239A1 (de)	2003-07-10
PL368940A1 (en)	2005-04-04
AU2002361990B2 (en)	2008-10-09
CA2470856A1 (en)	2003-07-03
PE20030741A1 (es)	2003-09-29
KR100959031B1 (ko)	2010-05-20
ZA200404149B (en)	2006-05-31
DE50208809D1 (de)	2007-01-04
JP2005516947A (ja)	2005-06-09
DK1461034T3 (da)	2007-03-26
TW200305408A (en)	2003-11-01
WO2003053434A1 (de)	2003-07-03
CN1606440A (zh)	2005-04-13
MY134344A (en)	2007-12-31
EP1461034B1 (de)	2006-11-22
HRP20040573A2 (en)	2004-10-31
RS53204A (sr)	2006-10-27
MA27149A1 (fr)	2005-01-03
AR037932A1 (es)	2004-12-22
BR0215154A (pt)	2004-10-19
ES2275945T3 (es)	2007-06-16
NO20043009L (no)	2004-07-15
MXPA04005388A (es)	2004-10-11
IL162562A (en)	2009-12-24
EP1461034A1 (de)	2004-09-29
CO5590925A2 (es)	2005-12-30
AU2002361990A1 (en)	2003-07-09
KR20040068322A (ko)	2004-07-30
HUP0600836A2 (en)	2008-04-28
JP4571803B2 (ja)	2010-10-27
CN100339079C (zh)	2007-09-26
ATE345797T1 (de)	2006-12-15

Publication	Publication Date	Title
IL160440A (en)	2009-09-01	Dihydropteridinones, method for producing the same and the use thereof as medicaments
MXPA03005018A (es)	2003-09-25	Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos, y su uso.
MXPA03005019A (es)	2003-09-25	Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos y su uso.
AU2003257465A1 (en)	2004-02-23	Substituted diaryl heterocycles, method for the production and use thereof as medicaments
MXPA03001483A (es)	2003-06-06	Heterociclos biciclicos medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion.
ZA200502247B (en)	2005-09-19	Selected CGRP antagonists, method for production and use thereof as medicament.
MXPA03000873A (es)	2003-06-06	Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos.
IL162669A0 (en)	2005-11-20	Antichlinergic agents, method for producing the same and use thereof as medicaments
MXPA03001510A (es)	2003-06-09	Heterociclos biciclicos, medicamentos que contiene estos compuestos, su empleo y procedimientos para su preparacion.
IL162316A0 (en)	2005-11-20	Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
PL376399A1 (en)	2005-12-27	Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
IL161893A0 (en)	2005-11-20	5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
IL165213A0 (en)	2005-12-18	Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilizationmedicament or diagnostic agent and medicament containing same
IL150228A0 (en)	2002-12-01	Substituted norbornylamino derivatives, method for the production thereof, use thereof as medicament or a diagnostic reagent and medicaments containing said compounds
HRP20041153A2 (en)	2005-06-30	Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
IL162562A0 (en)	2005-11-20	Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid
ZA200601001B (en)	2007-03-28	Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicament comprising the same
MXPA03007550A (es)	2003-12-04	Derivados coloporosidos, proceso para su preparacion y su uso.
PL370271A1 (en)	2005-05-16	Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
SI1513834T1 (sl)	2006-06-30	Substituirani tiofeni, postopek za njihovo pripravo, njihova uporaba kot zdravilo ali kot diagnostik kot tudi zdravilo, ki jih vsebuje
ZA200205696B (en)	2003-11-26	Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same.
MXPA03008636A (es)	2003-12-08	Derivados de isoquinuclidina, metodo para fabricar los mismos y agentes terapeuticos que contienen estos compuestos.
SI1509498T1 (sl)	2007-04-30	Pentafluorosulfanil-benzoilgvanidini, postopek za njihovo pripravo, njihova uporaba kot zdravilo ali diagnosticno sredstvo in zdravilo, ki jih vsebuje
SI1456212T1 (sl)	2007-04-30	Derivati 6-aminomorfinana, postopek za njihovo izdelavo in njihova uporaba
SI1560826T1 (sl)	2006-08-31	Spojine piridopirimidinona, postopek za njihovo pripravo in farmacevtski sestavki, ki te vsebujejo